Wedbush Securities
STAB

Wedbush Securities’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Wedbush Securities’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,321
Closed -$22K – 1024
2020
Q1 		$22K Buy
+13,321
New +$27.2K ﹤0.01% 859

Other funds holding STAB

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
B. Riley Wealth Advisors
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Wedbush Securities's STAB Position: Q2 2020 in Review

Wedbush Securities sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q2 2020, closing a stake of 13,321 shares — an estimated $22K sold.

Wedbush Securities first reported a position in STAB in Q1 2020 and held it in 1 quarter. The position peaked at $22K in Q1 2020. 17 funds tracked by Wall St. Rank hold STAB as of Q2 2020.

  • Wedbush Securities reported no remaining Statera Biopharma, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Wedbush Securities sold 13,321 Statera Biopharma, Inc. Common Stock shares in Q2 2020, an estimated $22K.
  • Wedbush Securities first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Wedbush Securities's Statera Biopharma, Inc. Common Stock position peaked at $22K in Q1 2020.
  • 17 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q2 2020.

Based on Wedbush Securities's 13F filing for Q2 2020, filed 16 Jul 2020.